Proceedings for Annual Meeting of The Japanese Pharmacological Society
Online ISSN : 2435-4953
The 94th Annual Meeting of the Japanese Pharmacological Society
Session ID : 94_1-P2-08
Conference information

Poster Sessions
Benzodiazepines and non-benzodiazepine drugs have direct vasorelaxant effects
*Satomi KagotaKana MorikawaHirotake IshidaJunko ChimotoKana FumotoShizuo Yamada,Kazumasa Shinozuka
Author information
CONFERENCE PROCEEDINGS OPEN ACCESS

Details
Abstract

Benzodiazepines (BDZs) and non-BDZ drugs are associated with side effects such as headaches, dizziness, and palpitations. Therefore, we evaluated whether these drugs have direct vasorelaxation effects onphenylephrine-contracted arteries isolated from Wistar rats using myography. The binding assay of the drugs for GABAAreceptors in rat brain was performed using [3H]flunitrazepam as an agonist. 

Zolpidem caused over 80% relaxation at a concentration of 10 μM in the thoracic aorta; diazepam, estazolam, etizolam, and tofisopam caused 60−70% relaxation, whereas alprazolam, bromazepam, brotizolam, chlordiazepoxide, clobazam, clonazepam, clorazepate, loflazepate, flunitrazepam, flurazepam, lorazepam, lormetazepam, midazolam, nimetazepam, nitrazepam, oxazepam, temazepam, triazolam, and zaleplon caused less than 50% relaxation. No correlation was observed between the GABAAreceptor binding affinity of the 23 drugs excluding tofisopam which had little binding affinity, and vascular relaxation.

The study demonstrated that many BDZs and non-BDZ drugs cause vasorelaxation. GABAAreceptor activation may not be mainly associated with vasorelaxation. The direct vasodilatory effects of these drugs may be partly involved in the mechanisms underlying their side effects.

Content from these authors
© 2021 The Authors(s)
Previous article Next article
feedback
Top